Search results for "Radiopharmaceuticals."

showing 10 items of 133 documents

Selective binding to monoamine oxidase A: in vitro and in vivo evaluation of (18)F-labeled β-carboline derivatives.

2015

In this study we synthesized four different (18)F-labeling precursors for the visualization of the monoamino oxidase A using harmol derivatives. Whereas two are for prosthetic group labeling using [(18)F]fluoro-d2-methyl tosylate and 2-[(18)F]fluoroethyl-tosylate, the other three precursors are for direct nucleophilic (18)F-labeling. Additionally the corresponding reference compounds were synthesized. The syntheses of [(18)F]fluoro-d2-methyl-harmol and 2-[(18)F]fluoroethyl-harmol were carried out using harmol as starting material. For direct nucleophilic (18)F-labeling of the tracers carrying oligoethyled spacers (PEG), a toluenesulfonyl leaving group was employed. The radiolabeling, purifi…

Fluorine RadioisotopesStereochemistryClinical BiochemistryPharmaceutical ScienceAlkylationIn Vitro TechniquesBiochemistryRats Sprague-Dawleychemistry.chemical_compoundDrug StabilityIn vivoDrug DiscoveryPEG ratioAnimalsHumansMolecular BiologyMonoamine OxidaseHarmolChemistryOrganic ChemistryLeaving groupLigand (biochemistry)In vitroRatsIsotope LabelingPositron-Emission TomographyMolecular MedicineRadiopharmaceuticalsSelectivityCarbolinesBioorganicmedicinal chemistry
researchProduct

Total synthesis and evaluation of [18F]MHMZ.

2007

Radiochemical labeling of MDL 105725 using the secondary labeling precursor 2-[(18)F]fluoroethyltosylate ([(18)F]FETos) was carried out in yields of approximately 90% synthesizing [(18)F]MHMZ in a specific activity of approximately 50MBq/nmol with a starting activity of approximately 3GBq. Overall radiochemical yield including [(18)F]FETos synthon synthesis, [(18)F]fluoroalkylation and preparing the injectable [(18)F]MHMZ solution was 42% within a synthesis time of approximately 100 min. The novel compound showed excellent specific binding to the 5-HT(2A) receptor (K(i)=9.0 nM) in vitro and promising in vivo characteristics.

Fluorine RadioisotopesStereochemistryClinical BiochemistryPharmaceutical ScienceBiochemistryBinding CompetitiveRadioligand AssayPiperidinesIn vivoDrug DiscoveryAnimalsRadionuclide imagingReceptor Serotonin 5-HT2ARadionuclide ImagingMolecular BiologyChemistryOrganic ChemistrySynthonTotal synthesisBrainBiological activityRadioligand AssayRatsFluorobenzenesKineticsYield (chemistry)Isotope LabelingSerotonin 5-HT2 Receptor AntagonistsMolecular MedicineSpecific activityKetanserinSerotonin AntagonistsRadiopharmaceuticalsNuclear chemistryBioorganicmedicinal chemistry letters
researchProduct

Efficient microwave-assisted direct radiosynthesis of [(18)F]PR04.MZ and [(18)F]LBT999: selective dopamine transporter ligands for quantitative molec…

2009

Abstract PR04.MZ 8-(4-fluoro-but-2-ynyl)-3- p -tolyl-8-aza-bicyclo[3.2.1]octane-2-carboxylic acid methyl ester ( 1 ) and LBT999 8-(( E )-4-fluoro-but-2-enyl)-3b- p -tolyl-8-aza-bicyclo[3.2.1]octane-2β-carboxylic acid methyl ester ( 2 ) are selective dopamine reuptake inhibitors, derived from cocaine. Compounds 1 and 2 were labelled with fluorine-18 at their terminally fluorinated N-substituents employing microwave enhanced direct nucleophilic fluorination. K[ 18 F]F − Kryptofix ® 222 cryptate, tetrabutyl ammonium [ 18 F]fluoride and caesium [ 18 F]fluoride were compared as fluoride sources under conventional and microwave enhanced conditions. Fluorination yields were remarkably increased un…

Fluorine RadioisotopesStereochemistryClinical BiochemistryPharmaceutical Sciencechemistry.chemical_elementCesiumLigandsBiochemistryChemical synthesischemistry.chemical_compoundFluoridesNucleophileCocaineDrug DiscoveryMicrowavesMolecular BiologyDopamine Plasma Membrane Transport ProteinsLigandOrganic ChemistryRadiosynthesischemistryModels ChemicalCaesiumIsotope LabelingPositron-Emission TomographyMolecular MedicineRadiopharmaceuticalsSelectivityAliphatic compoundFluorideNuclear chemistryTropanesBioorganicmedicinal chemistry
researchProduct

Synthesis of No-Carrier-Added 4-[18F]Fluorophenol from 4-Benzyloxyphenyl-(2-thienyl)iodonium Bromide

2011

4-[(18)F]Fluorophenol is a versatile synthon for the synthesis of more complex radiopharmaceuticals bearing a 4-[(18)F]fluorophenoxy moiety. In order to prepare 4-[(18)F]fluorophenol in no-carrier-added (n.c.a.) form only a nucleophilic labelling method starting from [(18)F]fluoride is suitable. In this paper a new, two step radiosynthesis starting from 4-benzyloxyphenyl-(2-thienyl)iodonium bromide and [(18)F]fluoride with subsequent deprotection is described, yielding n.c.a. [(18)F]fluorophenol in 34 to 36% radiochemical yield.

Fluorine Radioisotopespositron emission tomographyTwo stepNo carrier addedPharmaceutical ScienceThiophenesMedicinal chemistryAnalytical Chemistrylcsh:QD241-441chemistry.chemical_compoundOnium CompoundsPhenolsNucleophilelcsh:Organic chemistryBromideDrug DiscoveryMoietyOrganic chemistryPhysical and Theoretical Chemistrydiaryl iodonium saltsCommunicationOrganic ChemistrySynthonRadiosynthesischemistryChemistry (miscellaneous)fluorine-18Molecular MedicineradiosynthesisRadiopharmaceuticalsFluoride4-[18F]fluorophenolMolecules
researchProduct

Quantification of pulmonary blood flow (PBF): validation of perfusion MRI and nonlinear contrast agent (CA) dose correction with H(2)15O positron emi…

2009

Validation of quantification of pulmonary blood flow (PBF) with dynamic, contrast-enhanced MRI is still missing. A possible reason certainly lies in difficulties based on the nonlinear dependence of signal intensity (SI) from contrast agent (CA) concentration. Both aspects were addressed in this study. Nine healthy pigs were examined by first-pass perfusion MRI using gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA) and HO positron emission tomography (PET) imaging. Calculations of hemodynamic parameters were based on a one-compartment model (MR) and a two-compartment model (PET). Simulations showed a significant error when assuming a linear relation between MR SI and CA dose in the …

Gadolinium DTPAPulmonary CirculationCalibration curveSwinemedia_common.quotation_subjectGadoliniumPerfusion ImagingHemodynamicschemistry.chemical_elementContrast MediaSensitivity and SpecificityStandard deviationOxygen RadioisotopesmedicineContrast (vision)AnimalsRadiology Nuclear Medicine and imagingmedia_commonmedicine.diagnostic_testbusiness.industryReproducibility of ResultsWaterMagnetic resonance imagingImage EnhancementchemistryPositron emission tomographyPositron-Emission TomographyRadiopharmaceuticalsNuclear medicinebusinessArtifactsPerfusionMagnetic Resonance AngiographyMagnetic resonance in medicine
researchProduct

(R)-NODAGA-PSMA: A Versatile Precursor for Radiometal Labeling and Nuclear Imaging of PSMA-Positive Tumors

2015

Purpose The present study aims at developing and evaluating an urea-based prostate specific membrane antigen (PSMA) inhibitor suitable for labeling with 111In for SPECT and intraoperative applications as well as 68Ga and 64Cu for PET imaging. Methods The PSMA-based inhibitor-lysine-urea-glutamate-coupled to the spacer Phe-Phe-D-Lys(suberoyl) and functionalized with the enantiomerically pure prochelator (R)-1-(1-carboxy-3-carbotertbutoxypropyl)-4,7-carbotartbutoxymethyl)-1,4,7-triazacyclononane ((R)-NODAGA(tBu)3), to obtain (R)-NODAGA-Phe-Phe-D-Lys(suberoyl)-Lys-urea-Glu (CC34). CC34 was labeled with 111In, 68Ga and 64Cu. The radioconjugates were further evaluated in vitro and in vivo in LNC…

Glutamate Carboxypeptidase IIMaleBiodistributionPathologymedicine.medical_specialtylcsh:MedicineGallium RadioisotopesAcetatesurologic and male genital diseasesHeterocyclic Compounds 1-RingMicechemistry.chemical_compoundPharmacokineticsIn vivoLNCaPImage Processing Computer-AssistedTumor Cells CulturedGlutamate carboxypeptidase IImedicineAnimalsHumansTissue Distributionlcsh:ScienceIncubationMice Inbred BALB CMultidisciplinaryChemistrylcsh:RProstatic NeoplasmsXenograft Model Antitumor AssaysMolecular biologyIn vitroPositron-Emission TomographyAntigens SurfaceUreaFemalelcsh:QRadiopharmaceuticalsResearch ArticlePLOS ONE
researchProduct

One-pot, direct incorporation of [11C]CO2 into carbamates.

2009

Why beat about the bush? An operationally simple and mild reaction based on the direct fixation of (11)CO(2) with 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) has been developed for the synthesis of (11)C-labeled carbamates at 75 degrees C within 10 minutes in radiochemical yields above 70% (see scheme). This strategy should be immediately useful for the construction of new radiotracers for positron emission tomography and other applications.

Isotopic labelingBridged Bicyclo CompoundsExtramuralChemistryPositron-Emission TomographyGeneral ChemistryCarbamatesCarbon RadioisotopesCarbon DioxideRadiopharmaceuticalsBridged Bicyclo Compounds HeterocyclicCatalysisNuclear chemistryAngewandte Chemie (International ed. in English)
researchProduct

Production and Radiochemical Separation of the Auger Electron Emitter140Nd

2000

Among the Auger electron emitters, the radiolanthanide 140Nd has some unique nuclear properties with potential for endoradiotherapeutic applications. In the present study, 140Nd was produced via the 140Ce(3He,3n) nuclear process at the FZ Julich CV28 cyclotron, irradiating CeO2 with 3He particles of 36 MeV primary energy. Yields of about 5 MBq 140Nd per microAh were experimentally obtained. Batch yields of > 100 MBq 140Nd were reached. 140Nd was separated in 75 +/- 5% radiochemical yield using a two-step process, first by extracting the bulk of the target material according to a Ce(IV)/Nd(III) separation, then by final ion exchange purification.

LanthanideCyclotronElectronsElectronlaw.inventionPhysical PhenomenalawPhysical phenomenaMedicineRadiology Nuclear Medicine and imagingNeodymiumRadioisotopesAuger electron spectroscopyRadiochemistryIon exchangebusiness.industryPhysicsRadiochemistryAuger electron emitterHematologyGeneral MedicineOncologyYield (chemistry)RadiopharmaceuticalsNuclear medicinebusinessActa Oncologica
researchProduct

Recycling of 3He from lung magnetic resonance imaging

2011

We have developed the means to recycle 3He exhaled by patients after imaging the lungs using magnetic resonance of hyperpolarized 3He. The exhaled gas is collected in a helium leak proof bag and further compressed into a steel bottle. The collected gas contains about 1–2% of 3He, depending on the amount administered and the number of breaths collected to wash out the 3He gas from the lungs. 3He is separated from the exhaled air using zeolite molecular sieve adsorbent at 77 K followed by a cold head at 8 K. Residual gaseous impurities are finally absorbed by a commercial nonevaporative getter. The recycled 3He gas features high purity, which is required for repolarization by metastability ex…

Leakbusiness.product_categoryContrast Mediachemistry.chemical_elementMolecular sieveHeliumAdsorptionIsotopesGetterImpurityAdministration InhalationBottlemedicineHumansRecyclingRadiology Nuclear Medicine and imagingLungHeliumChromatographymedicine.diagnostic_testChemistryMagnetic resonance imagingEquipment DesignMagnetic Resonance ImagingEquipment Failure AnalysisExhalationRadiopharmaceuticalsbusinessMagnetic Resonance in Medicine
researchProduct

Effects of tetrahydrocannabinol on glucose uptake in the rat brain

2017

Δ9-Tetrahydrocannabinol (THC) is the psychoactive component of the plant Cannabis sativa and acts as a partial agonist at cannabinoid type 1 and type 2 receptors in the brain. The goal of this study was to assess the effect of THC on the cerebral glucose uptake in the rat brain. 21 male Sprague Dawley rats (12-13 w) were examined and received five different doses of THC ranging from 0.01 to 1 mg/kg. For data acquisition a Focus 120 small animal PET scanner was used and 24.1-28.0 MBq of [18F]-fluoro-2-deoxy-d-glucose were injected. The data were acquired for 70 min and arterial blood samples were collected throughout the scan. THC, THC-OH and THC-COOH were determined at 55 min p.i. Nine volu…

Male0301 basic medicineCannabinoid receptormedicine.medical_treatmentGlucose uptakeStimulationPharmacologyPartial agonistRats Sprague-Dawley03 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicineFluorodeoxyglucose F18Tandem Mass Spectrometrymental disordersmedicineAnimalsDronabinolTetrahydrocannabinolCannabinoid Receptor AgonistsPharmacologyBrain MappingPsychotropic DrugsDose-Response Relationship DrugChemistryorganic chemicalsBrainGlucose030104 developmental biologyPositron-Emission TomographyCerebellar cortexArterial bloodCannabinoidRadiopharmaceuticals030217 neurology & neurosurgeryChromatography Liquidmedicine.drugNeuropharmacology
researchProduct